Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes
- PMID: 2258190
- DOI: 10.1111/j.1600-065x.1990.tb00572.x
Functional dichotomy between Langerhans cells that present antigen to naive and to memory/effector T lymphocytes
Abstract
The general thrust of this volume is to review the roles of accessory cells in regulating T and B lymphocytes. To that end, we have summarized the evidence that indicates the crucial role that Langerhans cells play in the induction and expression of immunity to antigens that gain access to, or arise within, skin. Langerhans cells accomplish this important goal by their abilities to (a) activate naive T cells to antigens not previously encountered by the host, and (b) activate memory/effector T cells specific for previously encountered antigens. Arguments have been advanced to support the view that the functional properties of Langerhans cells used to present antigens to naive T cells differ substantially from the properties that equip Langerhans cells to activate effector T cells. The arguments are based in part on the fact that Langerhans cells carry out these functions in two very different environments: in the epidermis, and in the draining lymph node. The arguments are also based on results of in vitro experiments that reveal distinct differences in antigen processing and presenting properties of Langerhans cells freshly obtained from mouse and human skin as compared to Langerhans cells that have been cultured in vitro for 2-3 days. We propose that freshly explanted Langerhans cells faithfully reflect the functional program of intraepidermal Langerhans cells, and are able to present antigen to memory/effector T cells that enter the epidermal compartment. To accomplish this task, epidermal LC pick up environmental antigens, process them with great efficiency, and then present them in situ, without further upregulation of "accessory" signals (cell-adhesion molecules, secretion of additional cytokines). They can carry out this function, even in the presence of TGFB--a a cytokine which is constitutively made by keratinocytes, and which we have found to profoundly inhibit antigen presentation by most other types of "professional" antigen-presenting cells. Intraepidermal Langerhans cells are also capable of carrying cutaneous antigens through the dermal epidermal junction and migrating to the draining lymph node. We further propose that cultured Langerhans cells are fated to present antigens to unprimed/naive T cells, and thereby to initiate immune responses to new cutaneous antigens. Cultured LC process antigens less efficiently than fresh cells, but their unique capacity to present antigen effectively to unprimed T cells rests chiefly on the fact that they have significantly upregulated cell surface adhesion molecules, expression of MHC molecules, and secretion of activating cytokines--the "accessory" signals that are required for arousing naive T cells.(ABSTRACT TRUNCATED AT 400 WORDS)
Similar articles
-
In vitro evidence that Langerhans cells can adopt two functionally distinct forms capable of antigen presentation to T lymphocytes.J Immunol. 1989 Dec 15;143(12):3925-33. J Immunol. 1989. PMID: 2592763
-
T-lymphocyte-activating properties of epidermal antigen-presenting cells from normal and psoriatic skin: evidence that psoriatic epidermal antigen-presenting cells resemble cultured normal Langerhans cells.J Invest Dermatol. 1991 Sep;97(3):454-60. doi: 10.1111/1523-1747.ep12481465. J Invest Dermatol. 1991. PMID: 1875046
-
[Cutaneous immune system].C R Seances Soc Biol Fil. 1994;188(3):207-21. C R Seances Soc Biol Fil. 1994. PMID: 7834504 Review. French.
-
Fresh and cultured Langerhans cells display differential capacities to activate hapten-specific T cells.J Immunol. 1993 Jan 1;150(1):59-66. J Immunol. 1993. PMID: 8417131
-
Speculations on the immunopathogenesis of psoriasis: T-cell violation of a keratinocyte sphere of influence.J Invest Dermatol. 1990 Nov;95(5 Suppl):20S-21S. doi: 10.1111/1523-1747.ep12505683. J Invest Dermatol. 1990. PMID: 16788622 Review.
Cited by
-
Immunological cells and functions in Gaucher disease.Crit Rev Oncog. 2013;18(3):197-220. doi: 10.1615/critrevoncog.2013004503. Crit Rev Oncog. 2013. PMID: 23510064 Free PMC article. Review.
-
Role of epidermal Langerhans' cells in the induction of protective immunity to Schistosoma mansoni in guinea-pigs.Immunology. 1995 Feb;84(2):233-40. Immunology. 1995. PMID: 7750999 Free PMC article.
-
In vitro analysis of the phenotypical and functional properties of the 4F7+ cutaneous accessory dendritic cell.Arch Dermatol Res. 1995;287(3-4):273-8. doi: 10.1007/BF01105078. Arch Dermatol Res. 1995. PMID: 7598532
-
Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans' cells.Immunology. 1996 Jun;88(2):284-8. doi: 10.1111/j.1365-2567.1996.tb00016.x. Immunology. 1996. PMID: 8690462 Free PMC article.
-
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.J Exp Med. 1996 Jan 1;183(1):87-97. doi: 10.1084/jem.183.1.87. J Exp Med. 1996. PMID: 8551248 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials